$ACAD bullish base breakout

62
Everyone's favorite pre-buyout biotech is showing a bullish rise out of consolidation.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.